Latest News & Updates
Complimentary In-House Counsel Passes Available
A limited number of complimentary passes are available for qualified in-house counsel. Apply now to secure your place.
Apply NowEarly Agenda Now Available!
Get a first look at the key sessions and critical patent litigation issues shaping this year’s Conference.
VIEW AGENDAThe Premier Forum for Paragraph IV and Hatch-Waxman Litigation
Join American Conference Institute’s 23rd Annual Paragraph IV Disputes Conference, the nation’s leading forum for pharmaceutical patent litigation, returning to New York. This must-attend event brings together brand and generic pharmaceutical companies, in-house counsel, private practice attorneys, members of the judiciary, and government representatives to explore the latest developments shaping Hatch-Waxman litigation.
Stay ahead of emerging legal, regulatory, and business challenges while gaining practical strategies from the industry’s leading voices.
Join your peers to:
- Benchmark strategies with leading ANDA litigators, in-house counsel, and regulators
- Examine the latest case law, PTAB developments, and litigation trends
- Build valuable connections with the leaders shaping pharmaceutical patent litigation
Conference Co-Chairs
Donna Meuth
Associate General Counsel
IP, Eisai Inc.
Charles Kim
Partner
Jones Day LLP
Members of the Judiciary
Christopher Burke
Magistrate Judge
U.S. District Court, District of Delaware
Jennifer Choe-Groves, Judge
U.S. Court of International Trade Court and Visiting Judge
U.S. District Court, District of Delaware
Joshua Wolson
District Judge
U.S. District Court, District of Eastern Pennsylvania
Zahid Quraishi
District Judge
U.S. District Court, District of New Jersey
ACI’s Hatch-Waxman Series Advisory Board
Comprised of senior in-house IP counsel from top brand and generic pharma companies, the Advisory Board guides ACI on key litigation trends and emerging issues to ensure leading-edge content and expert faculty.
View Advisory Board
3,700+
Attendees
560+
Speakers
110+
Sponsors
Who Should Attend
Patent attorneys and litigators (in-house & law firms) who represent:
- Brand name pharmaceutical companies
- Generic pharmaceutical companies
- Biopharmaceutical companies
Earn CLE/Ethics Credits
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.
Learn moreSponsors & Partners
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]